Primary aldosteronism: A Japanese perspective

Fumitoshi Satoh; Ryo Morimoto; Yoshitsugu Iwakura; Yoshikiyo Ono; Masataka Kudo; Kei Takase; Sadayoshi Ito

doi:10.1007/s11154-011-9161-9

Primary aldosteronism: A Japanese perspective

Fumitoshi Satoh, Ryo Morimoto, Yoshitsugu Iwakura, Yoshikiyo Ono, Masataka Kudo, Kei Takase, Sadayoshi Ito

Research output: Contribution to journal › Review article › peer-review

9 Citations (Scopus)

Abstract

Primary aldosteronism (PA) is the most common cause of secondary hypertension, accounting for 10% of all hypertension. Far from being benign, hypertension due to PA is associated with high cardiovascular morbidity and mortality. However, PA is still underdiagnosed in general practice. Recent reports strongly recommend that identifying patients with PA is cost-beneficial based on improved cardiovascular outcomes afforded by specific surgical and medical treatment. This review provides an update of PA including controversial aspects of diagnosis and treatment.

Original language	English
Pages (from-to)	11-14
Number of pages	4
Journal	Reviews in Endocrine and Metabolic Disorders
Volume	12
Issue number	1
DOIs	https://doi.org/10.1007/s11154-011-9161-9
Publication status	Published - 2011 Mar

Keywords

Adrenal venous sampling
Aldosterone producing adenoma
Laparoscopic adrenalectomy
Mineralocorticoid receptor antagonists
Primary aldosreronism

ASJC Scopus subject areas

Endocrinology, Diabetes and Metabolism
Endocrinology

Access to Document

10.1007/s11154-011-9161-9

Fingerprint Dive into the research topics of 'Primary aldosteronism: A Japanese perspective'. Together they form a unique fingerprint.

Cite this

@article{f3f97d7a9fe24d9e80edee0faebcbd49,

title = "Primary aldosteronism: A Japanese perspective",

abstract = "Primary aldosteronism (PA) is the most common cause of secondary hypertension, accounting for 10% of all hypertension. Far from being benign, hypertension due to PA is associated with high cardiovascular morbidity and mortality. However, PA is still underdiagnosed in general practice. Recent reports strongly recommend that identifying patients with PA is cost-beneficial based on improved cardiovascular outcomes afforded by specific surgical and medical treatment. This review provides an update of PA including controversial aspects of diagnosis and treatment.",

keywords = "Adrenal venous sampling, Aldosterone producing adenoma, Laparoscopic adrenalectomy, Mineralocorticoid receptor antagonists, Primary aldosreronism",

author = "Fumitoshi Satoh and Ryo Morimoto and Yoshitsugu Iwakura and Yoshikiyo Ono and Masataka Kudo and Kei Takase and Sadayoshi Ito",

year = "2011",

month = mar,

doi = "10.1007/s11154-011-9161-9",

language = "English",

volume = "12",

pages = "11--14",

journal = "Reviews in Endocrine and Metabolic Disorders",

issn = "1389-9155",

publisher = "Springer Netherlands",

number = "1",

}

TY - JOUR

T1 - Primary aldosteronism

T2 - A Japanese perspective

AU - Satoh, Fumitoshi

AU - Morimoto, Ryo

AU - Iwakura, Yoshitsugu

AU - Ono, Yoshikiyo

AU - Kudo, Masataka

AU - Takase, Kei

AU - Ito, Sadayoshi

PY - 2011/3

Y1 - 2011/3

N2 - Primary aldosteronism (PA) is the most common cause of secondary hypertension, accounting for 10% of all hypertension. Far from being benign, hypertension due to PA is associated with high cardiovascular morbidity and mortality. However, PA is still underdiagnosed in general practice. Recent reports strongly recommend that identifying patients with PA is cost-beneficial based on improved cardiovascular outcomes afforded by specific surgical and medical treatment. This review provides an update of PA including controversial aspects of diagnosis and treatment.

AB - Primary aldosteronism (PA) is the most common cause of secondary hypertension, accounting for 10% of all hypertension. Far from being benign, hypertension due to PA is associated with high cardiovascular morbidity and mortality. However, PA is still underdiagnosed in general practice. Recent reports strongly recommend that identifying patients with PA is cost-beneficial based on improved cardiovascular outcomes afforded by specific surgical and medical treatment. This review provides an update of PA including controversial aspects of diagnosis and treatment.

KW - Adrenal venous sampling

KW - Aldosterone producing adenoma

KW - Laparoscopic adrenalectomy

KW - Mineralocorticoid receptor antagonists

KW - Primary aldosreronism

UR - http://www.scopus.com/inward/record.url?scp=79956062163&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79956062163&partnerID=8YFLogxK

U2 - 10.1007/s11154-011-9161-9

DO - 10.1007/s11154-011-9161-9

M3 - Review article

C2 - 21305358

AN - SCOPUS:79956062163

VL - 12

SP - 11

EP - 14

JO - Reviews in Endocrine and Metabolic Disorders

JF - Reviews in Endocrine and Metabolic Disorders

SN - 1389-9155

IS - 1

ER -